Insider Transactions in Q2 2024 at Colgate Palmolive CO (CL)
Insider Transaction List (Q2 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 14
2024
|
Jennifer Daniels CLO and Secretary |
SELL
Open market or private sale
|
Direct |
22,250
-27.15%
|
$2,091,500
$94.15 P/Share
|
May 14
2024
|
Jennifer Daniels CLO and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
22,250
+21.35%
|
$1,602,000
$72.29 P/Share
|
May 13
2024
|
Martina Hundmejean Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,905
+15.33%
|
-
|
May 13
2024
|
John T Cahill Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,905
+6.62%
|
-
|
May 13
2024
|
Kimberly A Nelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,905
+20.9%
|
-
|
May 13
2024
|
C Martin Harris Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,905
+8.24%
|
-
|
May 13
2024
|
Lisa Edwards Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,905
+12.11%
|
-
|
May 13
2024
|
Steven A Cahillane Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,905
+28.76%
|
-
|
May 13
2024
|
Lorrie M Norrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,905
+5.27%
|
-
|
May 13
2024
|
John P Bilbrey Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,905
+5.59%
|
-
|
May 13
2024
|
Brian Newman Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,587
+46.75%
|
-
|
May 09
2024
|
Panagiotis Tsourapas Grp Pres, Eur& Developing Mkts |
SELL
Open market or private sale
|
Direct |
12,000
-70.1%
|
$1,128,000
$94.15 P/Share
|
May 09
2024
|
Panagiotis Tsourapas Grp Pres, Eur& Developing Mkts |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+41.21%
|
$864,000
$72.29 P/Share
|
May 09
2024
|
Sally Massey Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
12,226
-46.75%
|
$1,149,244
$94.06 P/Share
|
May 09
2024
|
Sally Massey Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,226
+31.86%
|
$880,272
$72.29 P/Share
|
May 07
2024
|
John W Kooyman Chief of Staff |
SELL
Open market or private sale
|
Direct |
3,497
-52.37%
|
$325,221
$93.47 P/Share
|
May 01
2024
|
John P Bilbrey Director |
SELL
Open market or private sale
|
Direct |
6,329
-17.31%
|
$575,939
$91.59 P/Share
|
May 01
2024
|
John P Bilbrey Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,329
+14.76%
|
$392,398
$62.04 P/Share
|
May 01
2024
|
Sally Massey Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
6,115
-30.52%
|
$556,465
$91.92 P/Share
|
May 01
2024
|
Sally Massey Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,115
+23.38%
|
$440,280
$72.29 P/Share
|
Apr 01
2024
|
John P Bilbrey Director |
BUY
Grant, award, or other acquisition
|
Direct |
240
+0.79%
|
$21,120
$88.36 P/Share
|
Apr 01
2024
|
Lorrie M Norrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
297
+0.91%
|
$26,136
$88.36 P/Share
|
Apr 01
2024
|
Brian Newman Director |
BUY
Grant, award, or other acquisition
|
Direct |
212
+45.3%
|
$18,656
$88.36 P/Share
|
Apr 01
2024
|
Lisa Edwards Director |
BUY
Grant, award, or other acquisition
|
Direct |
106
+0.88%
|
$9,328
$88.36 P/Share
|